國家衛生研究院 NHRI:Item 3990099045/11771

NHRI > Institute of Biotechnology and Pharmaceutical Research > Teng-Kuang Yeh > Periodical Articles > Item 3990099045/11771

Please use this identifier to cite or link to this item: http://ir.nhri.org.tw/handle/3990099045/11771

Title:	Synthesis and evaluation of novel 7H-pyrrolo-[2,3-d]pyrimidine derivatives as potential anticancer agents
Authors:	Liu, YM;Chen, CH;Yeh, TK;Liou, JP
Contributors:	Institute of Biotechnology and Pharmaceutical Research
Abstract:	AIM: Bladder cancer is a highly recurrent urologic malignancy with limited treatment approaches. Previously, we reported compound 11 is a FGFR3 inhibitor with significant antibladder cancer activity. MATERIALS & METHODS: In this study, a series of 7H-pyrrolo-[2,3-d]pyrimidine derivatives were synthesized through ring formation and modification of compound 11 for anticancer activity evaluation. RESULTS: Compound 13i is the most effective agent against human RT-112 bladder cancer cells. Notably, 13i strongly inhibits CK1delta without affecting FGFR3 activity. We generated 13i HCl to increase solubility and showed profound cell cycle accumulation at the sub-G1 phase and apoptosis in CK1delta-overexpressed bladder and ovarian cancer cells. CONCLUSION: These results indicate that compound 13i could be a lead compound for further development of novel anticancer agents.
Date:	2019-05
Relation:	Future Medicinal Chemistry. 2019 May;11(9):959-974.
Link to:	http://dx.doi.org/10.4155/fmc-2018-0564
JIF/Ranking 2023:	http://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&SrcAuth=NHRI&SrcApp=NHRI_IR&KeyISSN=1756-8919&DestApp=IC2JCR
Cited Times(WOS):	https://www.webofscience.com/wos/woscc/full-record/WOS:000474891700005
Cited Times(Scopus):	https://www.scopus.com/inward/record.url?partnerID=HzOxMe3b&scp=85067596772
Appears in Collections:	[Teng-Kuang Yeh] Periodical Articles

Files in This Item:

There are no files associated with this item.

Loading...